<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase enzyme (NOS) possesses the unique ability to be "uncoupled" to produce <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> (<z:chebi fb="0" ids="15379">O(2)</z:chebi>(-)) instead of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) </plain></SENT>
<SENT sid="1" pm="."><plain>Reduced NO bioavailability as a result of NOS uncoupling has been speculated to play an essential role in <z:e sem="disease" ids="C0741949" disease_type="Disease or Syndrome" abbrv="">cardiovascular pathologies</z:e> including <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reperfusion injury, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>NO serves many important roles in the heart including stimulation of adenylate cyclase (AC) at low levels or guanalyl cyclase (sGC) at higher levels, or by s-nitrosylation of intracellular Ca(2+) regulatory proteins thus altering excitation-contraction coupling </plain></SENT>
<SENT sid="3" pm="."><plain>Not surprisingly, NOS uncoupling is an emerging therapeutic target in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Restoring proper NOS activity by increasing intracellular levels of its cofactor tetrahydrobiopterin (<z:chebi fb="5" ids="30157">BH4</z:chebi>) is effective in the management of hypertensive diastolic dysfunction, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>New evidence is constantly emerging highlighting the importance of NOS uncoupling in <z:e sem="disease" ids="C0741949" disease_type="Disease or Syndrome" abbrv="">cardiovascular pathologies</z:e> thus the purpose of this mini-review is to showcase the new advances and promising treatments for NOS uncoupling in CV disease </plain></SENT>
</text></document>